Company Registration No. 14074369 (England and Wales)
Vista Pharm Ltd
Unaudited accounts
for the year ended 31 July 2025
Vista Pharm Ltd
Unaudited accounts
Contents
Vista Pharm Ltd
Company Information
for the year ended 31 July 2025
Company Number
14074369 (England and Wales)
Registered Office
92 The Drive
Isleworth
Middlesex
TW7 4AD
England
Accountants
P10 Accountancy Ltd
Egerton House
68 Baker Street
Weybridge
KT13 8AL
Vista Pharm Ltd
Statement of financial position
as at 31 July 2025
Intangible assets
585,178
617,688
Tangible assets
12,805
15,972
Cash at bank and in hand
164,669
66,238
Creditors: amounts falling due within one year
(454,638)
(352,366)
Net current assets/(liabilities)
54,126
(21,220)
Total assets less current liabilities
652,109
612,440
Creditors: amounts falling due after more than one year
(397,811)
(437,617)
Net assets
254,298
174,823
Called up share capital
1
1
Profit and loss account
254,297
174,822
Shareholders' funds
254,298
174,823
For the year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 24 April 2026 and were signed on its behalf by
Ishpal Rihal
Director
Company Registration No. 14074369
Vista Pharm Ltd
Notes to the Accounts
for the year ended 31 July 2025
Vista Pharm Ltd is a private company, limited by shares, registered in England and Wales, registration number 14074369. The registered office is 92 The Drive, Isleworth, Middlesex, TW7 4AD, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
25% Straight Line
Computer equipment
25% Straight Line
Intangible fixed assets (including purchased goodwill) are included at cost less accumulated amortisation.
The amortisation policy is 5% straight line.
Inventories have been valued at the lower of cost and estimated selling price less costs to complete and sell. In respect of work in progress and finished goods, cost includes a relevant proportion of overheads according to the stage of manufacturing/completion.
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
Vista Pharm Ltd
Notes to the Accounts
for the year ended 31 July 2025
Basic financial instruments are recognised at amortised cost, except for investments in non-convertible preference and non-puttable ordinary shares which are measured at fair value, with changes recognised in profit or loss. Derivative financial instruments are initially recorded at cost and thereafter at fair value with changes recognised in profit or loss.
The tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible.
The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
4
Intangible fixed assets
Goodwill
Charge for the year
32,510
5
Tangible fixed assets
Fixtures & fittings
Computer equipment
Total
Cost or valuation
At cost
At cost
At 1 August 2024
16,743
6,078
22,821
Additions
1,799
1,585
3,384
At 31 July 2025
18,542
7,663
26,205
At 1 August 2024
4,186
2,663
6,849
Charge for the year
4,635
1,916
6,551
At 31 July 2025
8,821
4,579
13,400
At 31 July 2025
9,721
3,084
12,805
At 31 July 2024
12,557
3,415
15,972
Vista Pharm Ltd
Notes to the Accounts
for the year ended 31 July 2025
Amounts falling due within one year
Trade debtors
134,254
7,932
Accrued income and prepayments
118,716
199,959
7
Creditors: amounts falling due within one year
2025
2024
Bank loans and overdrafts
20,235
19,865
Trade creditors
194,490
173,851
Taxes and social security
62,138
34,679
Other creditors
1,556
16,971
Loans from directors
167,200
106,743
8
Creditors: amounts falling due after more than one year
2025
2024
Bank loans
397,811
437,617
Allotted, called up and fully paid:
1 Ordinary shares of £1 each
1
1
10
Average number of employees
During the year the average number of employees was 6 (2024: 5).